Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
News
- Global Report · Sep 23 at 10:12 AM
U.S. Niche Equities and Leveraged ETFs See Surprising Mid-2026 Activity
- Global Report · Sep 16 at 10:12 AM
M&A and Fundamental Divergence Send Clear Signals: Corporate Strategy Resets Behind 10 Niche US Equities
- Global Report · Aug 18 at 10:12 AM
The Great Pivot: How a Mismatched Cohort of SPACs, Biotechs, and Legacy Giants Are Navigating the New Economic Reality
- PUBT · Jul 7 at 10:03 AM
Semnur signs term sheet for $100 million unregistered share sale to iHolding Group at $10 per share
